articlePharmacogenetics and GenomicsFeb 1, 2008Closed access

A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Inserm · Université Toulouse III - Paul Sabatier · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Stevens-Johnson syndrome (SJS) and its severe form, toxic epidermal necrolysis (TEN), are rare but life-threatening cutaneous adverse reactions to drugs, especially to allopurinol, carbamazepine, lamotrigine, phenobarbital, phenytoine, sulfamethoxazole, oxicam and nevirapine. Recently, a strong association between carbamazepine and allopurinol induced SJS or TEN has been described with respectively, HLA-B*1502 and HLA-B*5801 in a Han Chinese population from Taiwan and other Asian countries.

Objective

The objective is to further investigate the relationship between SJS/TEN and HLA-B in a large number of patients in a European population.

Citation impact

619
total citations
FWCI
39.90
Percentile
100%
References
29
Citations per year

Authors

14

Topics & keywords

Keywords
  • Toxic epidermal necrolysis
  • Lamotrigine
  • Allopurinol
  • Carbamazepine
  • Medicine
  • Dermatology
  • Nevirapine
  • Population
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.